๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Emily Bodnar

Stock Analyst at H.C. Wainwright

(0.23)
# 4,712
Out of 5,162 analysts
701
Total ratings
30%
Success rate
-3.6%
Average return

Stocks Rated by Emily Bodnar

Autolus Therapeutics
Nov 2, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $0.9796
Upside: +920.82%
Nkarta
Nov 2, 2026
Initiated Coverage: Buy
Price Target: $14 → $12
Current: $1.12
Upside: +971.43%
Artiva Biotherapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $35
Current: $3.83
Upside: +813.84%
Arcus Biosciences
Sep 25, 2026
Reiterated: Buy
Price Target: $45
Current: $15.78
Upside: +185.17%
Agenus
Sep 21, 2026
Reiterated: Buy
Price Target: $25
Current: $6.14
Upside: +307.17%
Geron
Sep 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.913
Upside: -
Jasper Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $600
Current: $10.75
Upside: +5,481.40%
Odyssey Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $44
Current: $18.34
Upside: +139.91%
Olema Oncology
Sep 21, 2026
Reiterated: Buy
Price Target: $36
Current: $7.15
Upside: +403.50%
Purple Biotech
Sep 21, 2026
Reiterated: Buy
Price Target: $17
Current: $1.53
Upside: +1,011.11%
Reiterated: Buy
Price Target: $7
Current: $1.74
Upside: +302.30%
Reiterated: Buy
Price Target: $78
Current: $64.88
Upside: +20.22%
Reiterated: Buy
Price Target: $42
Current: $16.36
Upside: +156.72%
Reiterated: Buy
Price Target: $57
Current: $44.46
Upside: +28.21%
Reiterated: Buy
Price Target: $31
Current: $2.28
Upside: +1,259.65%
Reiterated: Buy
Price Target: $25
Current: $0.565
Upside: +4,324.78%
Reiterated: Buy
Price Target: $35
Current: $8.61
Upside: +306.50%
Reiterated: Buy
Price Target: $19
Current: $1.40
Upside: +1,257.14%
Reiterated: Buy
Price Target: $20
Current: $6.78
Upside: +194.99%
Rated: Buy
Price Target: $52 → $60
Current: $39.86
Upside: +50.53%
Reiterated: Buy
Price Target: $5
Current: $0.1686
Upside: +2,865.60%
Reiterated: Buy
Price Target: $10
Current: $2.91
Upside: +243.64%
Reiterated: Buy
Price Target: $52 → $55
Current: $28.76
Upside: +91.24%
Rated: Buy
Price Target: $46 → $52
Current: $10.69
Upside: +386.44%
Rated: Hold
Price Target: n/a
Current: $1.75
Upside: -
Reiterated: Buy
Price Target: $12
Current: $2.79
Upside: +330.11%
Reiterated: Buy
Price Target: $55 → $66
Current: $47.40
Upside: +39.24%
Initiated Coverage: Buy
Price Target: $18
Current: $3.67
Upside: +390.46%
Reiterated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Reiterated: Buy
Price Target: $57.35
Current: $4.66
Upside: n/a
Reiterated: Buy
Price Target: $160
Current: $1.26
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $1.30
Upside: n/a
Reiterated: Buy
Price Target: $8
Current: $0.6282
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.2839
Upside: n/a